Simona Erşcoiu - Concepedia

Author

Simona Erşcoiu

Also Known As

C. Oprişan, Livia Dragonu, Robert Bornstein, S Erşcoiu, S. Erscoiu, S. Rugina, S.M. Erscoiu, Simona Erscoiu, Simona Erşcoiu, Simona M Erscoiu

Publications

411

Citations

H-Index

Concepts

All Affiliations

Simona Erşcoiu is an author at Université Paris Cité specializing in medicine, hiv, and clinical trials.

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	325
2	Clinical Trials	3	3	257
3	Epidemiology	1	1	68
4	Neurology	1	1	68
5	Pathology	1	1	68

Simona Erşcoiu

Publications

325

Citations

H-Index

Page 1

	Year	Citations
Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3, non-inferiority trial Jean‐Michel Molina, Kathleen Squires, Paul E. Sax, The Lancet HIV Treatment And PreventionAntiviral Drug DevelopmentClinical TrialsAntiviral TherapyNon-inferiority Trial	2018	140
Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 96-week results of a randomised, double-blind, non-inferiority, phase 3 trial Jean‐Michel Molina, Kathleen Squires, Paul E. Sax, The Lancet HIV Treatment And PreventionAntiretroviral-naive AdultsClinical TrialsAntiviral Drug DevelopmentAntiviral Therapy	2019	92
Clinical manifestations in the West Nile virus outbreak. Emanoil Ceaușu, Simona Erşcoiu, Petre Iacob Calistru, PubMed PathogenesisPathologyVirologyMeningoencephalitis CasesDisease Outbreak	1999	68
Safety and efficacy of doravirine as first-line therapy in adults with HIV-1: week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trials Chloe Orkin, Jean‐Michel Molina, Pedro Cahn, The Lancet HIV First-line TherapyOpen-label ExtensionsAntiviral Drug DevelopmentClinical TrialsAntiviral Therapy	2023	25

Page 1